Annidis Corporation is a Canada-based company, which develops and markets imaging technologies to eye care professionals. The Company has developed a multi-spectral imaging system for retinal and choroidal assessment (the RHA). Its Annidis RHA is an ocular pathology management system to aid in early detection and management of age related macular degeneration (AMD), diabetic retinopathy and glaucoma. Its RHA collects and combines multi-spectral information. The RHA integrates advanced multi-spectral imaging with analytic software for early detection and management of ocular pathologies. The RHA uses multi-spectral imaging to take pictures of the retinal layers of eye. The Company's RHA Gold is used by eye care professionals as a tool for detecting early-onset of eye related diseases such as Dry AMD. The Company's RHA Platinum, which is under development with beta units in clinical testing, allows doctors to visualize choroidal and retinal vasculature non-invasively.